About Stephen Collins
Stephen Collins is a director at Immuno Cancer Biotherapeutics.
Experience
This experience comes from SEC filings. The years are when the filings name Stephen Collins in the role, so the role may have started earlier or lasted longer.
Immuno Cancer Biotherapeutics, Inc.
Director
2026 · Canton, SD
Develops antibody-based therapies intended to treat cancer.
Key Colleagues at Startups
The people Stephen Collins works with at each company, as listed on that company's latest Form D.
Immuno Cancer Biotherapeutics, Inc. · Form D, Oct 15, 2026
JR
James Robl
Co-founder, President and CSO, director